| |
| |
|
| Insider
Information: |
Kranzler Jay D |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
134,308 |
|
|
Indirect Shares
|
96,742 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
231,050 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cypress Bioscience Inc |
CYPB |
CEO, Director |
2010-12-28 |
625 |
2010-12-28 |
96,742 |
Premium* |
|
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2021-12-17 |
133,683 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2018-08-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
14,663 |
64,663 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-05-29 |
4 |
AS |
$0.00 |
$1,664 |
I/I |
(15,000) |
158,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-06-25 |
4 |
AS |
$0.00 |
$0 |
I/I |
(15,000) |
143,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2005-08-23 |
4 |
AS |
$12.17 |
$194,269 |
I/I |
(15,700) |
145,800 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO and Secretary |
• • – |
2004-06-01 |
4 |
OE |
$2.50 |
$55,177 |
I/I |
17,333 |
141,500 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2005-08-22 |
4 |
AS |
$12.90 |
$260,861 |
I/I |
(20,000) |
161,500 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2005-08-22 |
4 |
OE |
$2.50 |
$50,000 |
I/I |
20,000 |
161,500 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2005-08-23 |
4 |
OE |
$2.50 |
$50,000 |
I/I |
20,000 |
181,500 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO and Secretary |
• • – |
2003-10-15 |
4 |
OE |
$3.09 |
$62,548 |
I/I |
20,242 |
55,727 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-10-22 |
4 |
AS |
$13.30 |
$323,891 |
I/I |
(24,000) |
44,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2006-05-15 |
4 |
AS |
$7.19 |
$179,789 |
I/I |
(24,679) |
223,324 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2006-05-15 |
4 |
OE |
$2.50 |
$61,698 |
I/I |
24,679 |
248,003 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-11-26 |
4 |
AS |
$11.23 |
$281,689 |
I/I |
(24,700) |
18,624 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-07-23 |
4 |
AS |
$0.00 |
$0 |
I/I |
(25,000) |
118,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-08-27 |
4 |
AS |
$0.00 |
$4,224 |
I/I |
(25,000) |
93,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2007-09-24 |
4 |
AS |
$14.52 |
$369,621 |
I/I |
(25,000) |
68,324 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2010-12-28 |
4 |
S |
$6.46 |
$161,500 |
I/I |
(25,000) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2010-12-28 |
4 |
OE |
$3.25 |
$81,250 |
I/I |
25,000 |
121,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2005-07-18 |
4 |
AS |
$13.03 |
$531,240 |
I/I |
(40,000) |
141,500 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2005-07-18 |
4 |
OE |
$2.50 |
$100,000 |
I/I |
40,000 |
181,500 |
|
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
Director |
– • – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
69,020 |
133,683 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
Chief Executive Officer |
• • – |
2006-01-09 |
4 |
D |
$5.68 |
$400,644 |
I/I |
(70,536) |
226,724 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-02-02 |
4 |
AS |
$8.50 |
$644,908 |
I/I |
(75,000) |
96,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-02-02 |
4 |
OE |
$2.51 |
$188,250 |
I/I |
75,000 |
171,742 |
0 |
- |
|
| CYPB |
Cypress Bioscience Inc |
CEO |
• • – |
2009-03-02 |
4 |
OE |
$2.51 |
$188,250 |
I/I |
75,000 |
171,742 |
0 |
- |
|
63 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
